GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Aim Pharm Inc (SZSE:002826) » Definitions » Short-Term Debt

Tibet Aim Pharm (SZSE:002826) Short-Term Debt : ¥11.0 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Tibet Aim Pharm Short-Term Debt?

Tibet Aim Pharm's Short-Term Debt for the quarter that ended in Mar. 2024 was ¥11.0 Mil.

Tibet Aim Pharm's quarterly Short-Term Debt increased from Sep. 2023 (¥10.0 Mil) to Dec. 2023 (¥11.0 Mil) but then declined from Dec. 2023 (¥11.0 Mil) to Mar. 2024 (¥11.0 Mil).

Tibet Aim Pharm's annual Short-Term Debt declined from Dec. 2020 (¥40.0 Mil) to Dec. 2021 (¥0.0 Mil) but then increased from Dec. 2021 (¥0.0 Mil) to Dec. 2022 (¥50.1 Mil).

Tibet Aim Pharm Short-Term Debt Historical Data

The historical data trend for Tibet Aim Pharm's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Aim Pharm Short-Term Debt Chart

Tibet Aim Pharm Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.00 70.00 40.00 - 50.05

Tibet Aim Pharm Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.00 50.00 10.00 11.01 11.00

Tibet Aim Pharm Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Tibet Aim Pharm Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Tibet Aim Pharm's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Tibet Aim Pharm (SZSE:002826) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Aim Pharm Inc (SZSE:002826) » Definitions » Short-Term Debt
Comparable Companies
SZSE:300391 SZSE:301075 SZSE:000590 SHSE:603079 SZSE:002433 SHSE:603139 SHSE:603963 BJSE:832735 SZSE:300254 SZSE:300519 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 6, Linqionggang Road, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region, Lhasa, CHN, 850000
Website
http://www.emyy.cn
Tibet Aim Pharm Inc is the pharmaceutical company based in China. It is mainly engaged in the research and development, production and sales of chemical drugs and proprietary Chinese medicines for common chronic disease such as diabetes and cardiovascular disease as well as medicines for gynecology and obstetrics. The company's products offering includes miglitol tablets, gualoupi injection, nalmefene hydrochloride injection, carbetocin injection; hongjin xiaojie tablets and aceclofenac enteric-coated tablets. The company also expanded its products in the treatment of antibiotic, antiallergic and digestive system.
Executives
Peng Hui Director
Pang Guo Qiang Directors, executives
Li Qian Jin Securities Affairs Representative
Liu Hang Supervisors

Tibet Aim Pharm (SZSE:002826) Headlines

No Headlines